Evidence map›Paper›PMID 35865338›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

Xiao-Chai-Hu Decoction Ameliorates Poly (I:C)-Induced Viral Pneumonia through Inhibiting Inflammatory Response and Modulating Serum Metabolism.

Feng Chen, Fei Qu, Yuehui Jia, Chengxin Wang, Yuejie Yu, Jiabao Liao, Min Lin, Fengjuan Chen, Zhijia Sun

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Protective effects ofFrontiers in pharmacology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Feng ChenJiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China.ORCID https://orcid.org/0000-0002-9120-189X
Fei QuJiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China.
Yuehui JiaJiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China.
Chengxin WangJiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China.
Yuejie YuJiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China.
Jiabao LiaoJiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China.
Min LinJiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China.
Fengjuan ChenJiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China.ORCID https://orcid.org/0000-0002-7199-4263
Zhijia SunThe Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.ORCID https://orcid.org/0000-0001-9263-9052
First Hospital of Jiaxing · CNGuangzhou University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viral pneumonia is widespread, progresses rapidly, and has a high mortality rate. Developing safe and effective therapies to treat viral pneumonia can minimize risks to public health and alleviate pressures on the associated health systems. Xiao-Chai-Hu (XCH) decoction can be used in the treatment of viral pneumonia. However, the mechanisms of XCH on viral pneumonia remain unclear. In this study, poly (I:C) was used to establish a mouse model of viral pneumonia, and the therapeutic effects of XCH on viral pneumonia were assessed. Furthermore, we evaluated the effects of XCH on inflammatory response. Lastly, untargeted metabolomics were used to study the metabolic regulatory mechanisms of XCH on viral pneumonia model mice. Our results showed that XCH treatment decreased the wet/dry ratio in lung tissue, total protein concentration, and total cell count in bronchoalveolar lavage fluid (BALF). H&E staining indicated that XCH treatment alleviated the pathological changes in lung. Moreover, XCH treatment decreased the levels of proinflammatory cytokines (IL-1

Identifiers

PMID35865338
PMCPMC9296287
OpenAlexW4285092119

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.